Cloudbreak Therapeutics, LLC   Report issue

For profit Phase 2
Founded: Irvine CA United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03049852
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Cloudbreak Therapeutics, LLC